Direct oral anticoagulant secondary prophylaxis vs Low molecular weight heparin secondary prophylaxis
Minor upper GI bleeding · patients with cancer with venous thromboembolism
It is very uncertain whether direct oral anticoagulant secondary prophylaxis changes minor upper GI bleeding compared with low molecular weight heparin secondary prophylaxis (very low certainty).
1 finding from 1 review
- Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer 2018 · Cochrane Headline outcomes onlyRR 1.03 [0.04, 25.97]2 studies · 1495 participantsVery low